摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-1-phenyl-2,5-pentanediol | 757954-64-6

中文名称
——
中文别名
——
英文名称
(S)-1-phenyl-2,5-pentanediol
英文别名
(S)-5-phenyl-pentane-1,4-diol;(4S)-5-phenylpentane-1,4-diol
(S)-1-phenyl-2,5-pentanediol化学式
CAS
757954-64-6
化学式
C11H16O2
mdl
——
分子量
180.247
InChiKey
SVZPBLXSRVVZCW-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    13
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-1-phenyl-2,5-pentanediol氯化亚砜 、 ruthenium trichloride 、 sodium periodate 作用下, 以 二氯甲烷乙腈 为溶剂, 反应 20.0h, 以67%的产率得到(4S)-4-benzyl-1,3,2-dioxathiepane-2,2-dioxide
    参考文献:
    名称:
    立体选择性环化和锥体反转策略的 P-Chirogenic Phospholane 合成
    摘要:
    报道了 P-chirogenic 单和双磷烷的制备。所证明的方法采用环状硫酸盐与初级膦在碱存在下的立体选择性环化,以生成“顺式”或“顺式/顺式”P-手性磷杂环戊烷,然后通过热诱导锥体反转提供“反式”或“反式/反式” “ P-chirogenic 磷烷。将一种“反式/反式”磷烷的铑络合物应用于底物前体对药物候选普瑞巴林的高度对映选择性不对称氢化。
    DOI:
    10.1021/ja048079l
  • 作为产物:
    描述:
    (S)-(2,3-epoxypropyl)benzene 在 lithium aluminium tetrahydride 、 乙醇sodium 作用下, 以 四氢呋喃 为溶剂, 反应 16.08h, 生成 (S)-1-phenyl-2,5-pentanediol
    参考文献:
    名称:
    Synthesis of Both Enantiomers of a P-Chirogenic 1,2-Bisphospholanoethane Ligand via Convergent Routes and Application to Rhodium-Catalyzed Asymmetric Hydrogenation of CI-1008 (Pregabalin)
    摘要:
    Both enantiomers of a P-chirogenic 1,2-bisphospholanoethane ligand are synthesized via two convergent methods. The first method relies on the chiral alkylation of 1 -((-)-menthoxy)phospholaneborane using a s-BuLi/(-)-sparteine derived chiral base. Only one enantiomer of the catalyst could be synthesized via this method because only one antipode of sparteine is available in nature. The second route relies on the combination of methylphosphine borane and a chiral 1,4-diol. Either enantiomer of the ligand can be synthesized via the second route from the appropriate enantiomer of the 1,4-diol. Asymmetric hydrogenation using catalyst precursor 36 on acetamidoacrylic acid derivatives provided modest to good enantioselectivity (77-95% ee) under low H-2 pressure (30 psi). Asymmetric hydrogenation of Cl-1008 (pregabalin) precursors, 39 and 40, provided good enantioselectivities (92%) at high catalyst loading (1 mol %) and low pressure (30 psi). Enantiomeric excesses dropped sharply with catalyst loading at this pressure. Increasing the pressure of H-2 caused a significant increase in enantiomeric excess for low catalyst loading reactions. Several studies were undertaken to further investigate the enantioselectivity dependence on both pressure and catalyst loading.
    DOI:
    10.1021/ja034715o
点击查看最新优质反应信息

文献信息

  • Preparation of P-chirogenic phospholanes and their use in asymmetric synthesis
    申请人:Hoge Stewart Garrett
    公开号:US20050222464A1
    公开(公告)日:2005-10-06
    Materials and methods for preparing P-chirogenic monophospholanes and bisphospholanes are disclosed. The methods employ stereoselective cyclization to generate the phospholane rings followed by pyramidal inversion to access a variety of P-chirogenic phospholanes. When bound to transition metals such as rhodium, the disclosed P-chirogenic phospholanes may be used as catalysts in asymmetric synthesis of valuable pharmaceutical chemical entities, including pregabalin.
    本文披露了制备P-手性单膦杂环和双膦杂环的材料和方法。该方法采用立体选择性环化来生成膦杂环,然后通过金字塔翻转来访问各种P-手性膦杂环。当与铑等过渡金属结合时,所披露的P-手性膦杂环可用作催化剂,在制备有价值的药物化学物质,包括pregabalin的不对称合成中使用。
  • PREPARATION OF P-CHIROGENIC PHOSPHOLANES AND THEIR USE IN ASYMETRIC SYNTHESIS
    申请人:Warner-Lambert Company LLC
    公开号:EP1735324A1
    公开(公告)日:2006-12-27
  • US7390931B2
    申请人:——
    公开号:US7390931B2
    公开(公告)日:2008-06-24
  • [EN] PREPARATION OF P-CHIROGENIC PHOSPHOLANES AND THEIR USE IN ASYMETRIC SYNTHESIS<br/>[FR] PREPARATION DE PHOSPHOLANES P-CHIROGENES ET UTILISATION DE CEUX-CI DANS UNE SYNTHESE ASYMETRIQUE
    申请人:WARNER LAMBERT CO
    公开号:WO2005095424A1
    公开(公告)日:2005-10-13
    Materials and methods for preparing P-chirogenic monophospholanes and bisphospholanes are disclosed. The methods employ stereoselective cyclization to generate the phospholane rings followed by pyramidal inversion to access a variety of P-chirogenic phospholanes. When bound to transition metals such as rhodium, the disclosed P-chirogenic phospholanes may be used as catalysts in asymmetric synthesis of valuable pharmaceutical chemical entities, including pregabalin.
  • Synthesis of Both Enantiomers of a P-Chirogenic 1,2-Bisphospholanoethane Ligand via Convergent Routes and Application to Rhodium-Catalyzed Asymmetric Hydrogenation of CI-1008 (Pregabalin)
    作者:Garrett Hoge
    DOI:10.1021/ja034715o
    日期:2003.8.1
    Both enantiomers of a P-chirogenic 1,2-bisphospholanoethane ligand are synthesized via two convergent methods. The first method relies on the chiral alkylation of 1 -((-)-menthoxy)phospholaneborane using a s-BuLi/(-)-sparteine derived chiral base. Only one enantiomer of the catalyst could be synthesized via this method because only one antipode of sparteine is available in nature. The second route relies on the combination of methylphosphine borane and a chiral 1,4-diol. Either enantiomer of the ligand can be synthesized via the second route from the appropriate enantiomer of the 1,4-diol. Asymmetric hydrogenation using catalyst precursor 36 on acetamidoacrylic acid derivatives provided modest to good enantioselectivity (77-95% ee) under low H-2 pressure (30 psi). Asymmetric hydrogenation of Cl-1008 (pregabalin) precursors, 39 and 40, provided good enantioselectivities (92%) at high catalyst loading (1 mol %) and low pressure (30 psi). Enantiomeric excesses dropped sharply with catalyst loading at this pressure. Increasing the pressure of H-2 caused a significant increase in enantiomeric excess for low catalyst loading reactions. Several studies were undertaken to further investigate the enantioselectivity dependence on both pressure and catalyst loading.
查看更多